Viewing Study NCT00941460


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-02-20 @ 1:33 PM
Study NCT ID: NCT00941460
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2009-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
Sponsor: Prof. Dr. Wolfgang Wick
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module